This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Sheila Dewitt: Innovator in Pharmaceutical Chemistry
Introduction
Sheila Dewitt is a notable inventor in the field of pharmaceutical chemistry. She has made significant contributions to the development of deuterium-enriched compounds that have potential therapeutic applications. Her work focuses on innovative methods of treatment for various diseases.
Latest Patents
Sheila Dewitt holds patents related to deuterium-enriched 2,4-thiazolidinediones and methods of treatment. One of her latest inventions includes 5-deuterium-enriched 2,4-thiazolidinediones, which are designed to provide effective treatment options. Another significant patent involves 3-deuterium-enriched 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-piperidine-2,6-diones, which are aimed at treating cancer and immune-related diseases.
Career Highlights
Sheila is currently associated with Deuterx, LLC, where she continues to advance her research in pharmaceutical innovations. Her work has garnered attention for its potential impact on treatment methodologies in the medical field.
Collaborations
Sheila collaborates with esteemed colleagues, including Vincent Jacques and Leonardus Van Der Ploeg, to further enhance her research and development efforts.
Conclusion
Sheila Dewitt is a pioneering inventor whose work in pharmaceutical chemistry is paving the way for new treatment options. Her innovative patents reflect her commitment to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile